Trial intelligence / Profile preview

Osteon III Collagen for Regenerative Endodontics in Immature Teeth

NCT06812351Phase 1Completed

Sponsor
Ain Shams University
Start
Mar 2020
Primary completion
Mar 2021
Modality
Nanoparticles, Implantable Devices, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 1, randomised trial of Osteon III collagen in pulp necrosis and periapical periodontitis (AP), sponsored by Ain Shams University. Primary endpoint: Root completion of immature teeth at 1 year. Started Mar 2020; status: completed.

02

Drugs

Osteon III collagen
03

Conditions

pulp necrosisperiapical periodontitis (AP)

Beyond the preview

Go deeper on NCT06812351.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06812351.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call